Metabolize
San Francisco, United States
◆ Total Raised
$3.2M
◆ Stage
seed
◆ Location
San Francisco, United States
◆ Founded
2024
◆ Team size
1-10
◆ Links
◆ About Metabolize
San Francisco-based consumer health startup developing metabolic health products based on Stanford Medicine research, focused on supporting consumers transitioning away from GLP-1 medications.
◆ What sets it apart
It commercializes Stanford Medicine-originated precision metabolite research intended to support natural satiety signaling without drugs, injections, or hormone activation.
◆ Sectors
◆ Business
Modeltransactional
CustomerConsumers seeking metabolic health, weight maintenance, appetite regulation, and muscle preservation after or alongside GLP-1 therapy.
◆ Notable
- Obtained an exclusive license to Stanford-originated intellectual property
- Developed NATLEAN, its first consumer product aimed at people transitioning off GLP-1 therapies
- Raised a $3.2 million seed round led by Astanor with participation from Maia Ventures, LongGame Venture, and SOSV
◆ Backing funds on Raise
- Astanor Growthseed
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Metabolize do?
San Francisco-based consumer health startup developing metabolic health products based on Stanford Medicine research, focused on supporting consumers transitioning away from GLP-1 medications.
Where is Metabolize based?
Metabolize is based in San Francisco, United States, founded in 2024.
How much has Metabolize raised?
Metabolize has raised $3.2M in tracked funding and is currently at the seed stage.
Who has invested in Metabolize?
Investors in Metabolize include Astanor, Maia Ventures, LongGame Venture and SOSV.